IP Library Granted Patent US 10,322,277
Granted Patent B2
US 10,322,277 · App. 13/300,955 · Granted Jun 18, 2019

Contrast media injector syringe inlet valve system

Inventor: Sidney D. Nystrom (Shoreview, MN)
Assignee: ACIST MEDICAL SYSTEMS, INC.
A61M39/24A61M5/007A61M5/14546A61M5/285F16K15/026F16K15/06A61B6/548A61M2005/287A61M2005/3106
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,322,277
App. No.
13/300,955
Granted
Jun 18, 2019
Kind
B2
Abstract

A syringe for injecting contrast injection media into a patient. An inlet valve system associated with the syringe, the inlet valve system operable with a contrast injection media having any viscosity within the range of about 1 cP to about 30 cP. An inlet valve system associated with the syringe, the inlet valve system including a valve member having a density of less than or equal to 1 gram per cubic centimeter. A contrast injector system with such a syringe.

Claims (40)

1. A syringe for injecting contrast injection media into a patient, comprising:

a main body configured to receive a plunger;

a fluid outlet port in fluid communication with the main body to deliver the contrast injection media to a patient;

a fluid inlet port in fluid communication with the main body to deliver the contrast injection media into the main body; and

an inlet valve system associated with the fluid inlet port, the inlet valve system being open as contrast injection media is delivered into the main body and closed when the contrast injection media is delivered to a patient, the inlet valve system including a valve member with a head section and a tail section extending longitudinally from a first end of the head section, a valve seat located above the valve member and a valve member retaining device located between the head section of the valve member and the main body, the head section on a second end opposite the first end having a seating surface that seats against the valve seat to close the inlet valve system when the contrast injection media is delivered to the patient, the tail section of the valve member extending within the valve member retaining device toward the main body, the valve member selectively movable in response to pressure in the main body between an open unseated position in which the tail section extends into the main body such that the contrast injection media travels along a length of the tail section into the main body and a closed seated position in contact with the valve seat.

2. The syringe of claim 1 , wherein the inlet valve system is operable with a contrast injection media having any viscosity within the range of 1 cP to 30 cP.

3. The syringe of claim 1 , wherein the inlet valve system is operable with a contrast injection media having any specific gravity within the range of 1 to 2.

4. The syringe of claim 1 , wherein the valve member has a density of less than or equal to 1 gram per cubic centimeter, and wherein the inlet valve system is operable with a contrast injection media having any viscosity within the range of 1 cP to 30 cp and any specific gravity within the range of 1 to 2.

5. The syringe of claim 1 , wherein the seating surface has at least one channel.

6. The syringe of claim 5 , the seating surface having a domed shape.

7. The syringe of claim 5 , wherein the channel has a scallop shape.

8. The syringe of claim 1 , wherein the valve member has an outer surface, the outer surface having at least one groove.

9. The syringe of claim 1 , wherein a portion of the valve member is opaque and a portion of the valve member is translucent.

10. The syringe of claim 1 , wherein the inlet valve system is located within the inlet port.

11. The syringe of claim 1 , the head section having an outer surface, the outer surface having at least one groove.

12. The syringe of claim 11 , wherein the groove has a flute shape.

13. The syringe of claim 1 , wherein the valve member retaining device comprises one or more tabs extending into the inlet port.

14. The syringe of claim 1 , wherein the valve member retaining device restricts the valve member from completely entering the main body.

15. The syringe of claim 1 , wherein the valve seat includes a gasket.

16. The syringe of claim 1 , wherein the valve member comprises polyethylene.

17. The syringe of claim 1 , wherein the valve member comprises polypropylene.

18. The syringe of claim 1 , wherein the tail section of the valve member extends within the valve member retaining device toward the main body when the seating surface seats against the valve seat.

19. A syringe for injecting contrast injection media into a patient, comprising:

a main body configured to receive a plunger;

a fluid outlet port in fluid communication with the main body to deliver the contrast injection media to a patient;

a fluid inlet port in fluid communication with the main body to deliver the contrast injection media into the main body; and

an inlet valve system associated with the fluid inlet port, the inlet valve system being open as contrast injection media is delivered into the main body and closed when the contrast injection media is delivered to a patient, the inlet valve system including a valve member having a head section and a tail section extending longitudinally from a first end of the head section, a valve seat located above the valve member, and a valve member retaining device located between the head section of the valve member and the main body, the head section on a second end opposite the first end having a seating surface that seats against the valve seat to close the inlet valve system when the contrast injection media is delivered to the patient, the tail section of the valve member extending within the valve member retaining device toward the main body, the valve member selectively movable in response to pressure in the main body between an open unseated position in which the tail section extends into the main body such that the contrast injection media travels along a length of the tail section into the main body and a closed seated position in contact with the valve seat, the inlet valve system operable with contrast injection media having any viscosity within the range of 1 cP to 30 cP.

20. The syringe of claim 19 , wherein the inlet valve system is operable with a contrast injection media having a specific gravity within the range of 1 to 2.

21. The syringe of claim 19 , wherein the valve member has a density of less than or equal to 1 gram per cubic centimeter.

22. The syringe of claim 19 , wherein the seating surface has a domed shape and at least one channel.

23. The syringe of claim 19 , wherein the valve member comprises a polymer selected from the group consisting of polypropylene, polyethylene, and a copolymer of polypropylene and polyethylene.

24. The syringe of claim 19 , wherein the tail section of the valve member extends within the valve member retaining device toward the main body when the seating surface seats against the valve seat.

25. A contrast media injector system for injecting contrast media into a patient comprising:

a plunger;

a syringe, the syringe having a main body within which the plunger is movable, the syringe having a fluid inlet port;

an inlet valve system associated with the fluid inlet port, the inlet valve system having a valve member with a head section and a tail section extending longitudinally from a first end of the head section, a valve seat positioned above the valve member, and a valve member retaining device located between the head section of the valve member and the main body, the head section on a second end opposite the first end having a seating surface that seats against the valve seat, the tail section of the valve member extending within the valve member retaining device toward the main body, the valve member being automatically actuatable into an open position, in which the tail section extends into the main body such that the contrast injection media travels along a length of the tail section into the main body, as a response to a rearward movement of the plunger relative to the syringe and automatically actuatable to seat the seating surface against the valve seat to close the inlet valve system during a forward movement of the plunger; and

a reservoir of contrast media, the reservoir being positioned relative to the syringe such that the reservoir is in communication with the inlet valve assembly.

26. The contrast injector system of claim 25 , wherein the head section has a cylindrical shape and the tail section has a cylindrical shape.

27. The contrast injector system of claim 25 , wherein the head section has a cylindrical shape and the tail section has a square cross-sectional shape.

28. The contrast injector system of claim 25 , wherein the tail section of the valve member extends within the valve member retaining device toward the main body when the seating surface seats against the valve seat.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 12, 2019
From: NYSTROM, SIDNEY D.
To: ACIST MEDICAL SYSTEMS, INC.
Reel/Frame 048867/0222 →
Continuity (2)
Provisional Application 61416993 · Nov 24, 2010
Related Publication 20120130236A1 · May 24, 2012
Cited By (21)
US 1,102,447 US 1,119,865 US 12,232,838 US 12,329,397 US 12,376,928 US 12,377,206 US 12,419,703 US 12,433,702 US 12,440,289 US 12,446,979 US 12,447,317 US 12,508,093 US 12,558,175 US 12,564,414 US 12,564,458 US 12,569,308 US 12,605,523 US 12,636,022 US 12,661,193 US 12,678,249 US 12,702,509